Phase II study of cisplatin/etoposide and endostar for extensive-stage small-cell lung cancer.
2011
Purpose
To investigate the efficacy and safety of endostar, a novel recombinant human endostatin, plus cisplatin, and etoposide in patients with extensive-stage small-cell lung cancer (ED-SCLC).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
29
References
23
Citations
NaN
KQI